Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-16-019195
Filing Date
2016-12-07
Accepted
2016-12-07 07:24:08
Documents
7
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k120716_canfite.htm 6-K 13975
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL MEETING OF SHAR f6k120716ex99i_canfite.htm EX-99.1 164000
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL f6k120716ex99ii_canfite.htm EX-99.2 11019
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH f6k120716ex99iii_canfite.htm EX-99.3 1453
5 GRAPHIC pg1img1_ex99-1.jpg GRAPHIC 11279
6 GRAPHIC proxya.jpg GRAPHIC 769950
7 GRAPHIC proxyb.jpg GRAPHIC 969229
  Complete submission text file 0001213900-16-019195.txt   2329846
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 162037615
SIC: 2834 Pharmaceutical Preparations